Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sumio Ohtsuki

Showing results (101-110 of 229) with videos related to

Pageof 23
Sort By:
Drug Metabolism and Pharmacokinetics|December 25, 2004
mRNA expression and amino acid transport characteristics of cultured human brain microvascular endothelial cells (hBME)Nobuo Umeki, Yoshiki Fukasawa, Sumio Ohtsuki, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 3, 2010
Involvement of multidrug resistance-associated protein 4 in efflux transport of prostaglandin E(2) across mouse blood-brain barrier and its inhibition by intravenous administration of cephalosporinsShin-ichi Akanuma, Ken-ichi Hosoya, Shingo Ito, et al.
Pharmaceutical Research|June 17, 2006
Major involvement of low-density lipoprotein receptor-related protein 1 in the clearance of plasma free amyloid beta-peptide by the liverChihiro Tamaki, Sumio Ohtsuki, Takeshi Iwatsubo, et al.
Journal of Neurochemistry|February 5, 2011
Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptorsYasuo Uchida, Sumio Ohtsuki, Yuki Katsukura, et al.
Fluids and Barriers of the CNS|October 22, 2011
Attenuation of prostaglandin E2 elimination across the mouse blood-brain barrier in lipopolysaccharide-induced inflammation and additive inhibitory effect of cefmetazoleShin-Ichi Akanuma, Yasuo Uchida, Sumio Ohtsuki, et al.
Pharmaceutical Research|March 16, 2012
Attenuation of phosphorylation by deoxycytidine kinase is key to acquired gemcitabine resistance in a pancreatic cancer cell line: targeted proteomic and metabolomic analyses in PK9 cellsKen Ohmine, Kei Kawaguchi, Sumio Ohtsuki, et al.
Journal of Neurochemistry|September 27, 2005
Distinct spatio-temporal expression of ABCA and ABCG transporters in the developing and adult mouse brainMasanori Tachikawa, Masahiko Watanabe, Satoko Hori, et al.
Fluids and Barriers of the CNS|June 14, 2013
A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood-brain barrier in ddY, FVB, and C57BL/6J miceYasuo Uchida, Masanori Tachikawa, Wataru Obuchi, et al.
Biological & Pharmaceutical Bulletin|October 4, 2021
Proteomics Analysis of Lymphatic Metastasis-Related Proteins Using Highly Metastatic Human Melanoma Cells Originated by Sequential in Vivo ImplantationKatsuyuki Chida, Yu Sakurai, Asa Ohtani, et al.
Journal of Proteome Research|July 9, 2024
Improving Proteomic Identification Using Narrow Isolation Windows with Zeno SWATH Data-Independent AcquisitionKongxin Gu, Haruka Kumabe, Takumi Yamamoto, et al.
Pageof 23

Showing results (101-110 of 229) with videos related to

Sort By:
Pageof 23
Drug Metabolism and Pharmacokinetics|December 25, 2004
mRNA expression and amino acid transport characteristics of cultured human brain microvascular endothelial cells (hBME)Nobuo Umeki, Yoshiki Fukasawa, Sumio Ohtsuki, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 3, 2010
Involvement of multidrug resistance-associated protein 4 in efflux transport of prostaglandin E(2) across mouse blood-brain barrier and its inhibition by intravenous administration of cephalosporinsShin-ichi Akanuma, Ken-ichi Hosoya, Shingo Ito, et al.
Pharmaceutical Research|June 17, 2006
Major involvement of low-density lipoprotein receptor-related protein 1 in the clearance of plasma free amyloid beta-peptide by the liverChihiro Tamaki, Sumio Ohtsuki, Takeshi Iwatsubo, et al.
Journal of Neurochemistry|February 5, 2011
Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptorsYasuo Uchida, Sumio Ohtsuki, Yuki Katsukura, et al.
Fluids and Barriers of the CNS|October 22, 2011
Attenuation of prostaglandin E2 elimination across the mouse blood-brain barrier in lipopolysaccharide-induced inflammation and additive inhibitory effect of cefmetazoleShin-Ichi Akanuma, Yasuo Uchida, Sumio Ohtsuki, et al.
Pharmaceutical Research|March 16, 2012
Attenuation of phosphorylation by deoxycytidine kinase is key to acquired gemcitabine resistance in a pancreatic cancer cell line: targeted proteomic and metabolomic analyses in PK9 cellsKen Ohmine, Kei Kawaguchi, Sumio Ohtsuki, et al.
Journal of Neurochemistry|September 27, 2005
Distinct spatio-temporal expression of ABCA and ABCG transporters in the developing and adult mouse brainMasanori Tachikawa, Masahiko Watanabe, Satoko Hori, et al.
Fluids and Barriers of the CNS|June 14, 2013
A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood-brain barrier in ddY, FVB, and C57BL/6J miceYasuo Uchida, Masanori Tachikawa, Wataru Obuchi, et al.
Biological & Pharmaceutical Bulletin|October 4, 2021
Proteomics Analysis of Lymphatic Metastasis-Related Proteins Using Highly Metastatic Human Melanoma Cells Originated by Sequential in Vivo ImplantationKatsuyuki Chida, Yu Sakurai, Asa Ohtani, et al.
Journal of Proteome Research|July 9, 2024
Improving Proteomic Identification Using Narrow Isolation Windows with Zeno SWATH Data-Independent AcquisitionKongxin Gu, Haruka Kumabe, Takumi Yamamoto, et al.
Pageof 23